Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Harding

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Amino Acids|November 19, 2018
Correction to: Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cellsSrinidi Mohan, Seema Patel, Ian Greenstein, et al.
Current Medical Research and Opinion|July 22, 2024
Understanding profiles of patients with treatment-resistant depression by stringency of health plan prior authorization criteria for approval of esketamine nasal sprayLisa Harding, Maryia Zhdanava, Aditi Shah, et al.
Frontiers in Neuroscience|April 23, 2025
Music mindfulness acutely modulates autonomic activity and improves psychological state in anxiety and depressionChristine Ramirez, Gertrude Asumpaame Alayine, Cyril Selase Kwaku Akafia, et al.
Contemporary Clinical Trials|March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocolSamuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
The Journal of Clinical Psychiatry|December 4, 2024
Difficult to Treat Depression: Focus on Approach, Algorithms, and AccessJordan F Karp, Roberta D Brinton, Jay C Fournier, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Amino Acids|November 19, 2018
Correction to: Metabolic relevance for N-hydroxy L-arginine reduction in estrogen-negative breast cancer cellsSrinidi Mohan, Seema Patel, Ian Greenstein, et al.
Current Medical Research and Opinion|July 22, 2024
Understanding profiles of patients with treatment-resistant depression by stringency of health plan prior authorization criteria for approval of esketamine nasal sprayLisa Harding, Maryia Zhdanava, Aditi Shah, et al.
Frontiers in Neuroscience|April 23, 2025
Music mindfulness acutely modulates autonomic activity and improves psychological state in anxiety and depressionChristine Ramirez, Gertrude Asumpaame Alayine, Cyril Selase Kwaku Akafia, et al.
Contemporary Clinical Trials|March 4, 2026
Non-inferiority, comparative effectiveness study of intravenous ketamine v. intranasal esketamine for treatment-resistant depression: The EQUIVALENCE trial protocolSamuel T Wilkinson, Sandhya Prashad, Rachel Dalthorp, et al.
The Journal of Clinical Psychiatry|December 4, 2024
Difficult to Treat Depression: Focus on Approach, Algorithms, and AccessJordan F Karp, Roberta D Brinton, Jay C Fournier, et al.
Pageof 2